HS code: 30
To | |
Direction | |
From | |
Period | |
Selection products |
Period | Total |
---|---|
2019 | $12.5 M |
2020 | $18.4 M |
Total: | $30.9 M |
Period | Weight, tons. |
---|---|
2019 | 2.1 |
2020 | 3.64 |
Total: | 5.74 |
Group product | 2019 | 2020 | Ch. | ∑ (2019-2020) | Ratio |
---|---|---|---|---|---|
06 3001: Glands and other organs for organo-therapeutic uses | --- | --- | --- | --- | 0% |
06 3002: Human blood; animal blood; vaccines, toxins, cultures of micro-organisms and similar products | $12.5 M | $18.4 M | 48% | $30.9 M | 100% |
06 3003: Medicaments consisting of two or more constituents, for retail sale | --- | --- | --- | --- | 0% |
06 3004: Medicaments consisting of mixed or unmixed products for retail sale | --- | --- | --- | --- | 0% |
06 3005: Wadding, gauze, bandages and similar articles | --- | --- | --- | --- | 0% |
06 3006: Pharmaceutical goods specified in note 4 to this chapter | --- | --- | --- | --- | 0% |
Total: | $12.5 M | $18.4 M | $30.9 M |
№ | Country | ∑ (2019-2020) | Ratio |
---|---|---|---|
1 | Japan | $30.9 M | 40.7% |
2 | Germany | $28.7 M | 37.8% |
3 | United States | $6.3 M | 8.3% |
4 | Switzerland | $3.8 M | 5% |
5 | Ireland | $3.3 M | 4.4% |
6 | United Kingdom | $2.2 M | 2.9% |
7 | Belgium | $551 K | 0.7% |
8 | South Korea | $98 K | 0.1% |
9 | India | $94.1 K | 0.1% |
10 | Belarus | $82.6 K | 0.1% |
11 | France | $1.12 K | 0% |
The total for all countries: | $76 M | 100% |
№ | Region | ∑ (2019-2020) | Ratio |
---|---|---|---|
1 | Moskva | $182 M | 68.8% |
2 | Bashkiriya | $30.9 M | 11.7% |
3 | Sankt-Peterburg | $20.7 M | 7.8% |
4 | Kalujskaya oblast | $19.2 M | 7.3% |
5 | Nijegorodskaya oblast | $5.6 M | 2.1% |
6 | Moskovskaya oblast | $5.4 M | 2.1% |
7 | Novosibirskaya oblast | $296 K | 0.1% |
8 | Smolenskaya oblast | $207 K | 0.1% |
9 | Primorskiy kray | $55.1 K | 0% |
10 | Tulskaya oblast | $40.6 K | 0% |
11 | Sverdlovskaya oblast | $23.2 K | 0% |
12 | Arhangelskaya oblast | $22.1 K | 0% |
13 | Irkutskaya oblast | $7.8 K | 0% |
14 | Samarskaya oblast | $209 | 0% |
By all regions: | $264 M | 100% |